Several other SNPs in CCL2, CCL5, NOD2, FGF2 were found to be associated with either risk of ER positive or negative breast cancer in either AA or EA women, although only the NOD2 SNP association with ER positive tumors differed between AA and EA women, and none have been examined in relation to breast cancer risk. This evidence concerns the gene FGF2 and breast carcinoma.